-
1
-
-
38849143765
-
Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators
-
Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nature Rev. Drug Discov. 7, 168-181 (2008
-
(2008)
Nature Rev. Drug Discov
, vol.7
, pp. 168-181
-
-
Supuran, C.T.1
-
2
-
-
80053563164
-
Interfering with pH regulation in tumors as a therapeutic strategy
-
Neri D, Supuran C T. Interfering with pH regulation in tumors as a therapeutic strategy. Nat. Rev. Drug Discov. 10, 767-778 (2011
-
(2011)
Nat. Rev. Drug Discov
, vol.10
, pp. 767-778
-
-
Neri, D.1
Supuran, C.T.2
-
3
-
-
35148870672
-
Carbonic anhydrase inhibitors Cloning, characterization and inhibition studies of the cytosolic isozyme III with sulfonamides
-
Nishimori I, Minakuchi T, Onishi S et al. Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with sulfonamides. Bioorg. Med. Chem. 15, 7229-7236 (2007
-
(2007)
Bioorg. Med. Chem
, vol.15
, pp. 7229-7236
-
-
Nishimori, I.1
Minakuchi, T.2
Onishi, S.3
-
4
-
-
1242318777
-
Carbonic anhydrase inhibitors inhibition of mitochondrial isozyme v with aromatic and heterocyclic sulfonamides
-
Vullo D, Franchi M, Gallori E et al. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. J. Med. Chem. 47, 1272-1279 (2004
-
(2004)
J. Med. Chem
, vol.47
, pp. 1272-1279
-
-
Vullo, D.1
Franchi, M.2
Gallori, E.3
-
5
-
-
34248220084
-
Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform va
-
Vitale RM, Pedone C, Amodeo P et al. Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA. Bioorg. Med. Chem. 15, 4152-4158 (2007
-
(2007)
Bioorg. Med. Chem
, vol.15
, pp. 4152-4158
-
-
Vitale, R.M.1
Pedone, C.2
Amodeo, P.3
-
6
-
-
33846458646
-
Carbonic anhydrase inhibitors dna cloning, characterization and inhibition studies of the human secretory isoform vi, a new target for sulfonamide and sulfamate inhibitors
-
Nishimori I, Minakuchi T, Onishi S, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. DNA cloning, characterization and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. J. Med. Chem. 50, 381-388 (2007
-
(2007)
J. Med. Chem
, vol.50
, pp. 381-388
-
-
Nishimori, I.1
Minakuchi, T.2
Onishi, S.3
Vullo, D.4
Scozzafava, A.5
Supuran, C.T.6
-
7
-
-
16244364782
-
Carbonic anhydrase inhibitors inhibition of the human cytosolic isozyme vii with aromatic and heterocyclic sulfonamides
-
Vullo D, Voipio J, Innocenti A et al. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg. Med. Chem. Lett. 15, 971-976 (2005
-
(2005)
Bioorg. Med. Chem. Lett
, vol.15
, pp. 971-976
-
-
Vullo, D.1
Voipio, J.2
Innocenti, A.3
-
8
-
-
1242303231
-
-
Supuran CT, Scozzafava A, Conway J (Eds . CRC, FL, USA, 25-43
-
Nishimori I. Carbonic Anhydrase-Its Inhibitors and Activators. Supuran CT, Scozzafava A, Conway J (Eds). CRC, FL, USA, 25-43 (2004
-
(2004)
Carbonic Anhydrase-Its Inhibitors and Activators
-
-
Nishimori, I.1
-
9
-
-
0037463790
-
Carbonic anhydrase inhibitors inhibition of the tumor-Associated isozyme ix with aromatic and heterocyclic sulfonamides
-
Vullo D, Franchi M, Gallori E et al. Carbonic anhydrase inhibitors. Inhibition of the tumor-Associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg. Med. Chem. Lett. 13, 1005-1009 (2003
-
(2003)
Bioorg. Med. Chem. Lett
, vol.13
, pp. 1005-1009
-
-
Vullo, D.1
Franchi, M.2
Gallori, E.3
-
10
-
-
16244377468
-
Carbonic anhydrase inhibitors Inhibition of the transmembrane isozyme XII with sulfonamides-A new target for the design of antitumor and antiglaucoma drugs
-
Vullo D, Innocenti A, Nishimori I et al. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-A new target for the design of antitumor and antiglaucoma drugsés Bioorg. Med. Chem. Lett. 15, 963-969 (2005
-
(2005)
Bioorg Med. Chem. Lett
, vol.15
, pp. 963-969
-
-
Vullo, D.1
Innocenti, A.2
Nishimori, I.3
-
11
-
-
84879407175
-
Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors
-
De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin. Drug Discov. 8, 793-810. (2013
-
(2013)
Expert Opin. Drug Discov
, vol.8
, pp. 793-810
-
-
De Simone, G.1
Alterio, V.2
Supuran, C.T.3
-
12
-
-
0024218271
-
Refined structure of human carbonic anhydrase II at 2.0 A resolution
-
Eriksson AE, Jones TA, Liljas A. Refined structure of human carbonic anhydrase II at 2.0 A resolution. Proteins 4, 274-282 (1988
-
(1988)
Proteins
, vol.4
, pp. 274-282
-
-
Eriksson, A.E.1
Jones, T.A.2
Liljas, A.3
-
13
-
-
58149330109
-
Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans
-
Schlicker C, Hall RA, Vullo D et al. Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans. J. Mol. Biol. 385, 1207-1220 (2009
-
(2009)
J. Mol. Biol
, vol.385
, pp. 1207-1220
-
-
Schlicker, C.1
Hall, R.A.2
Vullo, D.3
-
14
-
-
84859422814
-
Structural and inhibition insights into carbonic anhydrase CDCA1 from the marine diatom Thalassiosira weissflogii
-
Alterio V, Langella E, Viparelli F et al. Structural and inhibition insights into carbonic anhydrase CDCA1 from the marine diatom Thalassiosira weissflogii. Biochimie 94, 1232-1241 (2012
-
(2012)
Biochimie
, vol.94
, pp. 1232-1241
-
-
Alterio, V.1
Langella, E.2
Viparelli, F.3
-
15
-
-
77249103054
-
Structural basis of the oxidative activation of the carboxysomal és -carbonic anhydrase, CcmM
-
Peña KL, Castel SE, de Araujo C et al. Structural basis of the oxidative activation of the carboxysomal és -carbonic anhydrase, CcmM. Proc. Natl Acad. Sci. USA 107, 2455-2460 (2010
-
(2010)
Proc. Natl Acad. Sci. USA
, vol.107
, pp. 2455-2460
-
-
Peña, K.L.1
Castel, S.E.2
De Araujo, C.3
-
16
-
-
84889385876
-
Carbonic anhydrases as drug targets: General presentation
-
Supuran CT, Winum JY (Eds). Wiley, NJ, USA
-
Supuran CT. Carbonic anhydrases as drug targets: General presentation. In: Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications. Supuran CT, Winum JY (Eds). Wiley, NJ, USA, 473-486 (2009
-
(2009)
Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications
, pp. 473-486
-
-
Supuran, C.T.1
-
17
-
-
0034018870
-
Carbonic anhydrase inhibitors and their therapeutic potential
-
Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin. Ther. Pat. 10, 575-600 (2000
-
(2000)
Expert Opin. Ther. Pat
, vol.10
, pp. 575-600
-
-
Supuran, C.T.1
Scozzafava, A.2
-
18
-
-
84865850354
-
Structure-based drug discovery of carbonic anhydrase inhibitors
-
Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J. Enzyme Inhib. Med. Chem. 27, 759-772 (2012
-
(2012)
J. Enzyme Inhib. Med. Chem
, vol.27
, pp. 759-772
-
-
Supuran, C.T.1
-
19
-
-
0037374846
-
Expression of cell surface transmembrane carbonic anhydrase genes ca9 and ca12 in the human eye: Overexpression of ca12 (caxii) in glaucoma
-
Liao SY, Ivanov S, Ivanova A et al. Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: Overexpression of CA12 (CAXII) in glaucoma. J. Med. Genet. 40, 257-261 (2003
-
(2003)
J. Med. Genet
, vol.40
, pp. 257-261
-
-
Liao, S.Y.1
Ivanov, S.2
Ivanova, A.3
-
25
-
-
84863501358
-
Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms
-
Alterio V, Di Fiore A, D'Ambrosio K, Supuran CT, De Simone G. Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoformsés Chem. Rev. 112, 4421-4468 (2012
-
(2012)
Chem Rev
, vol.112
, pp. 4421-4468
-
-
Alterio, V.1
Di Fiore, A.2
D'Ambrosio, K.3
Supuran, C.T.4
De Simone, G.5
-
26
-
-
84889476926
-
X-ray christallography of carbonic anhydrase inhibitors and its importance in drug design Inhibitors
-
Supuran CT, Winum JY (Eds) Wiley, NJ, USA
-
Alterio V, Di Fiore A, D'Ambrosio K, Supuran CT, De Simone G. X-ray christallography of carbonic anhydrase inhibitors and its importance in drug design Inhibitors. In: Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications. Supuran CT, Winum JY (Eds) Wiley, NJ, USA, 155-170 (2009
-
(2009)
Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications
, pp. 155-170
-
-
Alterio, V.1
Di Fiore, A.2
D'Ambrosio, K.3
Supuran, C.T.4
De Simone, G.5
-
27
-
-
84865850354
-
Structure-based drug discovery of carbonic anhydrase inhibitors
-
Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J. Enzyme Inhib. Med. Chem. 27, 759-772 (2012
-
(2012)
J. Enzyme Inhib. Med. Chem
, vol.27
, pp. 759-772
-
-
Supuran, C.T.1
-
29
-
-
0014135426
-
Carbonic anhydrase: Chemistry, physiology and inhibition
-
Maren TH. Carbonic anhydrase: Chemistry, physiology and inhibition. Physiol. Rev. 47, 595-781 (1967
-
(1967)
Physiol. Rev
, vol.47
, pp. 595-781
-
-
Maren, T.H.1
-
30
-
-
0001176531
-
Sulphanilamide as specific carbonic anhydrase inhibitor
-
Mann T, Keilin T. Sulphanilamide as specific carbonic anhydrase inhibitor. Nature 146, 164-165 (1940
-
(1940)
Nature
, vol.146
, pp. 164-165
-
-
Mann, T.1
Keilin, T.2
-
31
-
-
0037103151
-
Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: Role of hydrogen-bonding networks in ligand binding and drug design
-
Abbate F, Supuran CT, Scozzafava A, Orioli P, Stubbs MT, Klebe G. Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: Role of hydrogen-bonding networks in ligand binding and drug design. J. Med. Chem. 45(17), 3583-3587 (2002
-
(2002)
J. Med. Chem
, vol.45
, Issue.17
, pp. 3583-3587
-
-
Abbate, F.1
Supuran, C.T.2
Scozzafava, A.3
Orioli, P.4
Stubbs, M.T.5
Klebe, G.6
-
32
-
-
84878083885
-
Antiglaucoma carbonic anhydrase inhibitors: A patent review
-
Masini E, Carta F, Scozzafava A, Supuran CT. Antiglaucoma carbonic anhydrase inhibitors: A patent review. Expert Opin. Ther. Pat. 23, 705-716 (2013
-
(2013)
Expert Opin. Ther. Pat
, vol.23
, pp. 705-716
-
-
Masini, E.1
Carta, F.2
Scozzafava, A.3
Supuran, C.T.4
-
33
-
-
84878072961
-
Diuretics with carbonic anhydrase inhibitory action: A patent and literature review 2005-2013)
-
Carta F, Supuran CT. Diuretics with carbonic anhydrase inhibitory action: A patent and literature review (2005-2013). Expert Opin. Ther. Pat. 23, 681-691 (2013
-
(2013)
Expert Opin. Ther. Pat
, vol.23
, pp. 681-691
-
-
Carta, F.1
Supuran, C.T.2
-
34
-
-
84878039351
-
Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: A patent review
-
Aggarwal M, Kondeti B, McKenna R. Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: A patent review. Expert Opin. Ther. Pat. 23, 717-724 (2013
-
(2013)
Expert Opin. Ther. Pat
, vol.23
, pp. 717-724
-
-
Aggarwal, M.1
Kondeti, B.2
McKenna, R.3
-
35
-
-
84878067755
-
Anticancer carbonic anhydrase inhibitors: A patent review 2008-2013)
-
Monti SM, Supuran CT, Simone G. Anticancer carbonic anhydrase inhibitors: A patent review (2008-2013). Expert Opin. Ther. Pat. 23, 737-749 (2013
-
(2013)
Expert Opin. Ther. Pat
, vol.23
, pp. 737-749
-
-
Monti, S.M.1
Supuran, C.T.2
Simone, G.3
-
36
-
-
0033990833
-
Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors
-
Sugrue MF. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Progr. Ret. Eye. Res. 19, 87-112 (2000
-
(2000)
Progr. Ret. Eye. Res
, vol.19
, pp. 87-112
-
-
Sugrue, M.F.1
-
37
-
-
0034014371
-
Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (azopt) brinzolamide dose-response study group
-
Silver LH. Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Brinzolamide dose-response study group. Surv. Ophthalmol. 44, 147-153 (2000
-
(2000)
Surv. Ophthalmol
, vol.44
, pp. 147-153
-
-
Silver, L.H.1
-
38
-
-
1842628633
-
Carbonic anhydrase inhibitors Design of selective, membrane-impermeant inhibitors targeting the human tumor-Associated isozyme IX
-
Casey JR, Morgan PE, Vullo D et al. Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-Associated isozyme IX. J. Med. Chem. 47, 2337-2347 (2004
-
(2004)
J. Med. Chem
, vol.47
, pp. 2337-2347
-
-
Casey, J.R.1
Morgan, P.E.2
Vullo, D.3
-
39
-
-
0034719437
-
Carbonic anhydrase inhibitors: Synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes
-
Scozzafava A, Briganti F, Ilies MA, Supuran CT. Carbonic anhydrase inhibitors: Synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. J. Med. Chem. 43, 292-300 (2000
-
(2000)
J. Med. Chem
, vol.43
, pp. 292-300
-
-
Scozzafava, A.1
Briganti, F.2
Ilies, M.A.3
Supuran, C.T.4
-
42
-
-
84905444289
-
-
Supuran CT, Scozzafava A: AU200368
-
Institute of Virology, Supuran CT, Scozzafava A: AU200368 (2010
-
(2010)
Institute of Virology
-
-
-
44
-
-
0031023338
-
Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans
-
Maus TL, Larsson LI, McLaren JW, Brubaker RF. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch Ophthalmol. 115, 45-49 (1997
-
(1997)
Arch Ophthalmol
, vol.115
, pp. 45-49
-
-
Maus, T.L.1
Larsson, L.I.2
McLaren, J.W.3
Brubaker, R.F.4
-
45
-
-
84878062801
-
Antiobesity carbonic anhydrase inhibitors: A literature and patent review
-
Scozzafava A, Supuran CT, Carta F. Antiobesity carbonic anhydrase inhibitors: A literature and patent review. Expert Opin. Ther. Pat. 23, 725-735 (2013
-
(2013)
Expert Opin. Ther. Pat
, vol.23
, pp. 725-735
-
-
Scozzafava, A.1
Supuran, C.T.2
Carta, F.3
-
46
-
-
84865994162
-
Diuretics with carbonic anhydrase inhibitory activity: Towards novel application for sulfonamide drugs
-
Supuran CT, Winum JY (Eds). Wiley, NJ, USA
-
Vullo D, Innocenti A, Supuran CT. Diuretics with carbonic anhydrase inhibitory activity: Towards novel application for sulfonamide drugs. In: Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications. Supuran CT, Winum JY (Eds). Wiley, NJ, USA, 473-486 (2009
-
(2009)
Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications
, pp. 473-486
-
-
Vullo, D.1
Innocenti, A.2
Supuran, C.T.3
-
47
-
-
0000729469
-
-
9th Edition. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (Eds). McGraw-Hill, NY, USA
-
Jackson EK. Diuretics. In: Goodman and Gilman's the pharmacological basis of therapeutics. 9th Edition. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (Eds). McGraw-Hill, NY, USA, 685-713 (1996
-
(1996)
Diuretics Goodman and Gilman's the Pharmacological Basis of Therapeutics
, pp. 685-713
-
-
Jackson, E.K.1
-
48
-
-
0022521289
-
Carbonic anhydrases isoenzymes in the rat kidney Effects of chronic acetazolamide treatment
-
Lonnerholm G, Wistrand PJ, Barany E. Carbonic anhydrases isoenzymes in the rat kidney. Effects of chronic acetazolamide treatment. Acta Physiol. Scand. 126, 51-60 (1986
-
(1986)
Acta Physiol. Scand
, vol.126
, pp. 51-60
-
-
Lonnerholm, G.1
Wistrand, P.J.2
Barany, E.3
-
49
-
-
1242348311
-
Role ofcarbonic anhydrase and its inhibitors inbiological science related togastroenterology, neurology andnephrology
-
Supuran CT, Scozzafava A, Conway J (Eds). CRC Press FL, USA
-
Parkkila S, Parkkila AK, Kivela J. Role ofcarbonic anhydrase and its inhibitors inbiological science related togastroenterology, neurology andnephrology. In: Carbonic anhydrase-its inhibitors and activators. Supuran CT, Scozzafava A, Conway J (Eds). CRC Press, FL, USA, 281-303 (2004
-
(2004)
Carbonic Anhydrase-its Inhibitors and Activators
, pp. 281-303
-
-
Parkkila, S.1
Parkkila, A.K.2
Kivela, J.3
-
50
-
-
0015910024
-
Histochemical demonstration of carbonic anhydrase in the human kidney
-
Lonnerholm G. Histochemical demonstration of carbonic anhydrase in the human kidney. Acta Physiol. Scand. 88, 455-469 (1973
-
(1973)
Acta Physiol. Scand
, vol.88
, pp. 455-469
-
-
Lonnerholm, G.1
-
51
-
-
0016161677
-
Distribution of carbonic anhydrase in the frog nephron
-
Lonnerholm G, Ridderstrale Y. Distribution of carbonic anhydrase in the frog nephron. Acta Physiol. Scand. 90, 764-778 (1974
-
(1974)
Acta Physiol. Scand
, vol.90
, pp. 764-778
-
-
Lonnerholm, G.1
Ridderstrale, Y.2
-
52
-
-
0018829928
-
Intracellular distribution of carbonic anhydrase in the rat kidney
-
Lonnerholm G, Ridderstrale Y. Intracellular distribution of carbonic anhydrase in the rat kidney. Kidney Int. 17, 162-174 (1980
-
(1980)
Kidney Int
, vol.17
, pp. 162-174
-
-
Lonnerholm, G.1
Ridderstrale, Y.2
-
53
-
-
0001690310
-
Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification
-
Sly WS, Hewett-Emmett D, Whyte MP et al. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc. Natl Acad. Sci. USA 80, 2752-2756 (1983
-
(1983)
Proc. Natl Acad. Sci. USA
, vol.80
, pp. 2752-2756
-
-
Sly, W.S.1
Hewett-Emmett, D.2
Whyte, M.P.3
-
54
-
-
36248979864
-
Ammonia excretion in rainbow trout (Oncorhynchus mykiss): Evidence for Rh glycoprotein and H+-ATPase involvement
-
Nawata CM, Hung CC, Tsui TK et al. Ammonia excretion in rainbow trout (Oncorhynchus mykiss): Evidence for Rh glycoprotein and H+-ATPase involvement. Physiol. Genomics 31, 463-474 (2007
-
(2007)
Physiol. Genomics
, vol.31
, pp. 463-474
-
-
Nawata, C.M.1
Hung, C.C.2
Tsui, T.K.3
-
55
-
-
0348140626
-
Renal and hepatic expression of the ammonium transporter proteins rh b glycoprotein and rh c glycoprotein
-
Weiner ID, Verlander JW. Renal and hepatic expression of the ammonium transporter proteins, Rh B Glycoprotein and Rh C Glycoprotein. Acta Physiol. Scand. 179, 331-338 (2003
-
(2003)
Acta Physiol. Scand
, vol.179
, pp. 331-338
-
-
Weiner, I.D.1
Verlander, J.W.2
-
56
-
-
42149114451
-
Diuretics: From classical carbonic anhydrase inhibitors to novel applications of the sulfonamides
-
Supuran CT. Diuretics: From classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. Curr. Pharm. Des. 14, 641-648 (2008
-
(2008)
Curr. Pharm. des
, vol.14
, pp. 641-648
-
-
Supuran, C.T.1
-
57
-
-
46749087889
-
Carbonic anhydrase inhibitors Sulfonamide diuretics revisited-old leads for new applications
-
Temperini C, Cecchi A, Scozzafava A et al. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited-old leads for new applicationsés Org. Biomol. Chem. 6, 2499-2506 (2008
-
(2008)
Org. Biomol. Chem
, vol.6
, pp. 2499-2506
-
-
Temperini, C.1
Cecchi, A.2
Scozzafava, A.3
-
58
-
-
41949096461
-
Carbonic anhydrase inhibitors interaction of indapamide and related diuretics with twelve mammalian isozymes and x-ray crystallographic studies for the indapamide-isozyme ii adduct
-
Temperini C, Cecchi A, Scozzafava A et al. Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with twelve mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct. Bioorg. Med. Chem. Lett. 18, 2567-2573 (2008
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, pp. 2567-2573
-
-
Temperini, C.1
Cecchi, A.2
Scozzafava, A.3
-
59
-
-
60549085611
-
Carbonic anhydrase inhibitors comparison of chlorthalidone and indapamide x-ray crystal structures in adducts with isozyme ii: When three water molecules and the ketoenol tautomerism make the difference
-
Temperini C, Cecchi A, Scozzafava A et al. Carbonic anhydrase inhibitors. Comparison of chlorthalidone and indapamide X-ray crystal structures in adducts with isozyme II: When three water molecules and the ketoenol tautomerism make the difference. J. Med. Chem. 52, 322-328 (2009
-
(2009)
J. Med. Chem
, vol.52
, pp. 322-328
-
-
Temperini, C.1
Cecchi, A.2
Scozzafava, A.3
-
60
-
-
58949083662
-
Carbonic anhydrase inhibitors comparison of chlorthalidone, indapamide, trichloromethiazide and furosemide x-ray crystal structures in adducts with isozyme ii, when several water molecules make the difference
-
Temperini C, Cecchi A, Scozzafava A et al. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide and furosemide x-ray crystal structures in adducts with isozyme II, when several water molecules make the difference. Bioorg. Med. Chem. 17, 1214-1221 (2009
-
(2009)
Bioorg. Med. Chem
, vol.17
, pp. 1214-1221
-
-
Temperini, C.1
Cecchi, A.2
Scozzafava, A.3
-
61
-
-
3442884580
-
Benzolamide is not a membraneimpermeant carbonic anhydrase inhibitor
-
Supuran CT, Scozzafava A. Benzolamide is not a membraneimpermeant carbonic anhydrase inhibitor. J. Enzyme Inhib. Med. Chem. 19, 269-273 (2004
-
(2004)
J. Enzyme Inhib. Med. Chem
, vol.19
, pp. 269-273
-
-
Supuran, C.T.1
Scozzafava, A.2
-
62
-
-
0032458423
-
Acetazolamide-induced increase in blood flow to rabbit organs is confirmed using colored microspheres
-
Taki K, Hirahara K, Tomita S et al. Acetazolamide-induced increase in blood flow to rabbit organs is confirmed using colored microspheres. Heart Vessels 13, 63-67 (1998
-
(1998)
Heart Vessels
, vol.13
, pp. 63-67
-
-
Taki, K.1
Hirahara, K.2
Tomita, S.3
-
64
-
-
0034932304
-
Preferential acetazolamide-induced vasodilation based on vessel size andorgan: Confirmation of peripheralvasodilation with use of colored microspheres
-
Taki K, Oogushi K, Hirahara K et al. Preferential acetazolamide-induced vasodilation based on vessel size andorgan: Confirmation of peripheralvasodilation with use of colored microspheres. Angiology 52, 483-488 (2001
-
(2001)
Angiology
, vol.52
, pp. 483-488
-
-
Taki, K.1
Oogushi, K.2
Hirahara, K.3
-
65
-
-
84856769409
-
Renal carbonicanhydrases are involved in the reabsorption of endogenous nitrite
-
Chobanyan-Jurgens K, Schwarz A, Bohmer A et al. Renal carbonicanhydrases are involved in the reabsorption of endogenous nitrite. Nitric Oxide 26, 126-131 (2012
-
(2012)
Nitric Oxide
, vol.26
, pp. 126-131
-
-
Chobanyan-Jurgens, K.1
Schwarz, A.2
Bohmer, A.3
-
71
-
-
84863225073
-
Ophthalmic drug discovery: Novel targets and mechanisms for retinal disease and glaucoma
-
Zhang K, Zhang L, Weinreb RN. Ophthalmic drug discovery: Novel targets and mechanisms for retinal disease and glaucoma. Nature Rev Drug Discov. 11, 541-559 (2012
-
(2012)
Nature Rev Drug Discov
, vol.11
, pp. 541-559
-
-
Zhang, K.1
Zhang, L.2
Weinreb, R.N.3
-
72
-
-
0000974035
-
Heterocyclic sulfonamides as carbonic anhydrase inhibitors
-
Miller WH, Dessert AM, Roblin RO Jr. Heterocyclic sulfonamides as carbonic anhydrase inhibitors. J. Am. Chem. Soc. 72, 4893-4896 (1950
-
(1950)
J. Am. Chem. Soc
, vol.72
, pp. 4893-4896
-
-
Miller, W.H.1
Dessert, A.M.2
Roblin Jr., R.O.3
-
73
-
-
0020630921
-
The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion
-
Maren TH, Jankowska L, Sanyal G et al. The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion. Exp. Eye Res. 36, 457-480 (1983
-
(1983)
Exp. Eye Res
, vol.36
, pp. 457-480
-
-
Maren, T.H.1
Jankowska, L.2
Sanyal, G.3
-
76
-
-
79956062824
-
Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action
-
Mincione F, Benedini F, Biondi S et al. Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action. Bioorg. Med. Chem. Lett. 21, 3216-3221 (2011
-
(2011)
Bioorg. Med. Chem. Lett
, vol.21
, pp. 3216-3221
-
-
Mincione, F.1
Benedini, F.2
Biondi, S.3
-
77
-
-
84855408335
-
A new approach to antiglaucoma drugs: Carbonic anhydrase inhibitors with or without no donating moieties mechanism of action and preliminary pharmacology
-
Fabrizi F, Mincione F, Somma T et al. A new approach to antiglaucoma drugs: Carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology. J. Enzyme Inhib. Med. Chem. 27, 138-147 (2012
-
(2012)
J. Enzyme Inhib. Med. Chem
, vol.27
, pp. 138-147
-
-
Fabrizi, F.1
Mincione, F.2
Somma, T.3
-
81
-
-
84872915972
-
A multivalent approach towards linkeddual-pharmacology prostaglandin Freceptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma
-
Long DD, Frieman B, Hegde SS et al. A multivalent approach towards linkeddual-pharmacology prostaglandin Freceptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma. Bioorg. Med. Chem. Lett. 23, 939-943 (2013
-
(2013)
Bioorg. Med. Chem. Lett
, vol.23
, pp. 939-943
-
-
Long, D.D.1
Frieman, B.2
Hegde, S.S.3
-
82
-
-
65349159298
-
Synthesis of novel nitric oxide (NO)-releasing esters of timolol
-
Chiroli V, Batugo MR, Biondi S et al. Synthesis of novel nitric oxide (NO)-releasing esters of timolol. Bioorg. Med. Chem. Lett. 19, 2785-2788 (2009
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, pp. 2785-2788
-
-
Chiroli, V.1
Batugo, M.R.2
Biondi, S.3
-
83
-
-
71749104748
-
Nitric oxidedonating carbonic anhydrase inhibitors for the treatment of open-Angle glaucoma
-
Steele RM, Batugo MR, Benedini F et al. Nitric oxidedonating carbonic anhydrase inhibitors for the treatment of open-Angle glaucoma. Bioorg. Med. Chem. Lett. 19, 6565-6570 (2009
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, pp. 6565-6570
-
-
Steele, R.M.1
Batugo, M.R.2
Benedini, F.3
-
84
-
-
84855408335
-
A new approach to antiglaucoma drugs: Carbonic anhydrase inhibitors with or without no donating moieties mechanism of action and preliminary pharmacology
-
Fabrizi F, Mincione F, Somma T et al. A new approach to antiglaucoma drugs: Carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology. J. Enzyme Inhib. Med. Chem. 27, 138-147 (2012
-
(2012)
J. Enzyme Inhib. Med. Chem
, vol.27
, pp. 138-147
-
-
Fabrizi, F.1
Mincione, F.2
Somma, T.3
-
90
-
-
77958022642
-
Inhibition and binding studies of carbonic anhydrase isozymes i II and IX with benzimidazo[1, 2-c] [1, 2, 3] thiadiazole-7-sulphonamides
-
Baranauskiene L, Hilvo M, Matuliene J et al. Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1, 2-c] [1, 2, 3] thiadiazole-7-sulphonamides. J. Enzyme Inhib. Med. Chem. 25, 863-870 (2010
-
(2010)
J. Enzyme Inhib. Med. Chem
, vol.25
, pp. 863-870
-
-
Baranauskiene, L.1
Hilvo, M.2
Matuliene, J.3
-
92
-
-
0037423243
-
Obesity-what is to be done
-
Kelner K, Helmuth L Obesity-what is to be doneés Science 299, 845 (2003
-
(2003)
Science
, vol.299
, pp. 845
-
-
Kelner, K.1
Helmuth, L.2
-
93
-
-
0037423144
-
Obesity and the environment: Where do we go from here
-
Hill OJ, Wyatt HR, Reed GW, Peters JC Obesity and the environment: Where do we go from hereés Science 299, 853-855 (2003
-
(2003)
Science
, vol.299
, pp. 853-855
-
-
Hill, O.J.1
Wyatt, H.R.2
Reed, G.W.3
Peters, J.C.4
-
94
-
-
0242551296
-
Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity
-
Supuran CT. Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity. Expert Opin. Ther. Pat. 13, 1545-1550 (2003
-
(2003)
Expert Opin. Ther. Pat
, vol.13
, pp. 1545-1550
-
-
Supuran, C.T.1
-
95
-
-
0033014606
-
Mood stabilization and weight loss with topiramate
-
Gordon A, Price LH. Mood stabilization and weight loss with topiramate. Am. J. Psychiatry. 156, 968 (1999
-
(1999)
Am. J. Psychiatry
, vol.156
, pp. 968
-
-
Gordon, A.1
Price, L.H.2
-
96
-
-
0034576649
-
Topiramate reduces energy and fat gains in lean (Fa/és ) and obese (fa/fa) Zucker rats
-
Picard F, Deshaies Y, Lalonde J et al. Topiramate reduces energy and fat gains in lean (Fa/és ) and obese (fa/fa) Zucker rats. Obes. Res. 8, 656-663 (2000
-
(2000)
Obes. Res
, vol.8
, pp. 656-663
-
-
Picard, F.1
Deshaies, Y.2
Lalonde, J.3
-
97
-
-
84874535324
-
Effect of sulfonamides as selective carbonic anhydrase VA and VB inhibitors on mitochondrial metabolic energy conversion
-
Arechederra RL, Waheed A, Sly WS, Supuran CT, Minteer SD. Effect of sulfonamides as selective carbonic anhydrase VA and VB inhibitors on mitochondrial metabolic energy conversion. Bioorg. Med. Chem. 21, 1544-1548 (2013
-
(2013)
Bioorg. Med. Chem
, vol.21
, pp. 1544-1548
-
-
Arechederra, R.L.1
Waheed, A.2
Sly, W.S.3
Supuran, C.T.4
Minteer, S.D.5
-
98
-
-
67650046728
-
Carbonic anhydrase inhibitors aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms va and vb
-
Guzel O, Innocenti A, Scozzafava A, Salman A, Supuran CT. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB. Bioorg. Med. Chem. 17, 4894-4899 (2009
-
(2009)
Bioorg. Med. Chem
, vol.17
, pp. 4894-4899
-
-
Guzel, O.1
Innocenti, A.2
Scozzafava, A.3
Salman, A.4
Supuran, C.T.5
-
99
-
-
0034115766
-
Topiramate as an inhibitor of carbonic anhydrase isoenzymes
-
Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41, S35-9 (2000
-
(2000)
Epilepsia
, vol.41
-
-
Dodgson, S.J.1
Shank, R.P.2
Maryanoff, B.E.3
-
109
-
-
84862777611
-
What is the prognosis for new centrally-Acting anti-obesity drugs
-
Heal DJ, Gosden J, Smith SL What is the prognosis for new centrally-Acting anti-obesity drugsés Neuropharmacology 63, 132-146 (2012
-
(2012)
Neuropharmacology
, vol.63
, pp. 132-146
-
-
Heal, D.J.1
Gosden, J.2
Smith, S.L.3
-
114
-
-
0002704056
-
Effects of carbon dioxide on brain excitability and electrolytes
-
Woodbury DM, Rollins LT, Gardner MD et al. Effects of carbon dioxide on brain excitability and electrolytes. Am. J. Physiol. 192, 79-90 (1958
-
(1958)
Am. J. Physiol
, vol.192
, pp. 79-90
-
-
Woodbury, D.M.1
Rollins, L.T.2
Gardner, M.D.3
-
115
-
-
0014043081
-
Mean carbon dioxide tension in the brain after carbonic anhydrase inhibition
-
Brzezinski J, Kjallquist A, Siesjo BK. Mean carbon dioxide tension in the brain after carbonic anhydrase inhibition. J. Physiol. 188, 13-23 (1967
-
(1967)
J. Physiol
, vol.188
, pp. 13-23
-
-
Brzezinski, J.1
Kjallquist, A.2
Siesjo, B.K.3
-
116
-
-
0014338043
-
The anticonvulsant action of carbon dioxide: Interaction with reserpine and inhibitors of carbonic anhydrase
-
Gray WD, Rauh CE. The anticonvulsant action of carbon dioxide: Interaction with reserpine and inhibitors of carbonic anhydrase. J. Pharmacol. Exp. Ther. 163, 431-438 (1968
-
(1968)
J. Pharmacol. Exp. Ther
, vol.163
, pp. 431-438
-
-
Gray, W.D.1
Rauh, C.E.2
-
117
-
-
0036091187
-
Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons
-
Leniger T, Wiemann M, Bingmann D, Widman G, Hufnagel A, Bonnet U. Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons. Epilepsia 43, 469-474 (2002
-
(2002)
Epilepsia
, vol.43
, pp. 469-474
-
-
Leniger, T.1
Wiemann, M.2
Bingmann, D.3
Widman, G.4
Hufnagel, A.5
Bonnet, U.6
-
118
-
-
0034961068
-
Acetazolamide in women with catamenial epilepsy
-
Lim LL, Foldvary N, Mascha E, Lee J. Acetazolamide in women with catamenial epilepsy. Epilepsia 42, 746-749 (2001
-
(2001)
Epilepsia
, vol.42
, pp. 746-749
-
-
Lim, L.L.1
Foldvary, N.2
Mascha, E.3
Lee, J.4
-
119
-
-
7044249708
-
Sulthiame in childhood epilepsy
-
Ben-Zeev B, Watemberg N, Lerman P, Barash I, Brand N, Lerman-Sagie T. Sulthiame in childhood epilepsy. Pediatr. Int. 46, 521-524 (2004
-
(2004)
Pediatr. Int
, vol.46
, pp. 521-524
-
-
Ben-Zeev, B.1
Watemberg, N.2
Lerman, P.3
Barash, I.4
Brand, N.5
Lerman-Sagie, T.6
-
120
-
-
37449024255
-
Deterioration in cognitive function in children with benign epilepsy of childhood with central temporal spikes treated with sulthiame
-
Wirrell E, Sherman EMS, Vanmastrigt R et al. Deterioration in cognitive function in children with benign epilepsy of childhood with central temporal spikes treated with sulthiame. J. Child Neurol. 23, 14-21 (2008
-
(2008)
J. Child Neurol
, vol.23
, pp. 14-21
-
-
Wirrell, E.1
Sherman, E.M.S.2
Vanmastrigt, R.3
-
121
-
-
35048891925
-
Topiramate: A review of its use in the treatment of epilepsy
-
Lyseng-Williamson KA, Yang LPH. Topiramate: A review of its use in the treatment of epilepsy. Drugs 67, 2231-2256 (2007
-
(2007)
Drugs
, vol.67
, pp. 2231-2256
-
-
Lyseng-Williamson, K.A.1
Yang, L.P.H.2
-
122
-
-
23844472863
-
Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting
-
Guerrini R, Carpay J, Groselj J et al. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting. Seizure 14, 371-380 (2005
-
(2005)
Seizure
, vol.14
, pp. 371-380
-
-
Guerrini, R.1
Carpay, J.2
Groselj, J.3
-
123
-
-
25144453313
-
Randomized dose-controlled study of topiramate as first-line therapy in epilepsy
-
Arroyo S, Dodson WE, Privitera MD et al. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol. Scand. 112, 214-222 (2005
-
(2005)
Acta Neurol. Scand
, vol.112
, pp. 214-222
-
-
Arroyo, S.1
Dodson, W.E.2
Privitera, M.D.3
-
124
-
-
0033023323
-
Inhibition of transient and persistent Na+current fractions by thenew anticonvulsant topiramate
-
Taverna S, Sancini G, Mantegazza M, Franceschetti S, Avanzini G. Inhibition of transient and persistent Na+current fractions by thenew anticonvulsant topiramate. J. Pharmacol. Exp. Ther. 288, 960-968 (1999
-
(1999)
J. Pharmacol. Exp. Ther
, vol.288
, pp. 960-968
-
-
Taverna, S.1
Sancini, G.2
Mantegazza, M.3
Franceschetti, S.4
Avanzini, G.5
-
125
-
-
0034040285
-
Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell culture
-
McLean MJ, Bukhari AA, Wamil AW. Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell culture. Epilepsia 41, S21-24 (2000
-
(2000)
Epilepsia
, vol.41
-
-
McLean, M.J.1
Bukhari, A.A.2
Wamil, A.W.3
-
126
-
-
0034076789
-
Modulation of high-voltage-Activated calcium channels in dentate granule cells by topiramate
-
Zhang X, Velumian AA, Jones OT, Carlen PL. Modulation of high-voltage-Activated calcium channels in dentate granule cells by topiramate. Epilepsia 41, S52-S60 (2000
-
(2000)
Epilepsia
, vol.41
-
-
Zhang, X.1
Velumian, A.A.2
Jones, O.T.3
Carlen, P.L.4
-
127
-
-
0034115767
-
Topiramate blocks kainate-evoked cobalt influx into cultured neurons
-
Skradski S, White HS. Topiramate blocks kainate-evoked cobalt influx into cultured neurons. Epilepsia 41, S45-S47 (2000
-
(2000)
Epilepsia
, vol.41
-
-
Skradski, S.1
White, H.S.2
-
128
-
-
35048891925
-
Topiramate: A review of its use in the treatment of epilepsy
-
Lyseng-Williamson KA, Yang LPH. Topiramate: A review of its use in the treatment of epilepsy. Drugs 67, 2231-2256 (2007
-
(2007)
Drugs
, vol.67
, pp. 2231-2256
-
-
Lyseng-Williamson, K.A.1
Yang, L.P.H.2
-
129
-
-
26844517863
-
Carbonic anhydrase IX (CA IX) as a potential target for cancer therapy
-
Pastorekova S, Zava J. Carbonic anhydrase IX (CA IX) as a potential target for cancer therapy. Cancer Ther. 2, 245-262 (2004
-
(2004)
Cancer Ther
, vol.2
, pp. 245-262
-
-
Pastorekova, S.1
Zava, J.2
-
130
-
-
0041062296
-
Human carbonic anhydrase XII: CDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers
-
Türeci O, Sahin U, Vollmar E et al. Human carbonic anhydrase XII: CDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc. Natl Acad. Sci. USA 95, 7608-7613 (1998
-
(1998)
Proc. Natl Acad. Sci. USA
, vol.95
, pp. 7608-7613
-
-
Türeci, O.1
Sahin, U.2
Vollmar, E.3
-
131
-
-
44849141442
-
Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas
-
Haapasalo J, Hilvo M, Nordfors K et al. Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas. Neuro Oncol. 10, 131-138 (2008
-
(2008)
Neuro Oncol
, vol.10
, pp. 131-138
-
-
Haapasalo, J.1
Hilvo, M.2
Nordfors, K.3
-
132
-
-
0035105565
-
Expression of the hypoxia-inducible and tumor-Associated carbonic anhydrases in ductal carcinoma in situ of the breast
-
Wykoff CC, Beasley N, Watson PH et al. Expression of the hypoxia-inducible and tumor-Associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am. J. Pathol. 158, 1011-1019 (2001
-
(2001)
Am. J. Pathol
, vol.158
, pp. 1011-1019
-
-
Wykoff, C.C.1
Beasley, N.2
Watson, P.H.3
-
133
-
-
33845515875
-
Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours
-
Hynninen P, Vaskivuo L, Saarnio J et al. Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours. Histopathology. 49, 594-602 (2006
-
(2006)
Histopathology
, vol.49
, pp. 594-602
-
-
Hynninen, P.1
Vaskivuo, L.2
Saarnio, J.3
-
134
-
-
0033775150
-
Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours
-
Kivela AJ, Parkkila S, Saarnio J et al. Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours. Histochem. Cell Biol. 114, 197-204 (2000
-
(2000)
Histochem. Cell Biol
, vol.114
, pp. 197-204
-
-
Kivela, A.J.1
Parkkila, S.2
Saarnio, J.3
-
135
-
-
0033902802
-
Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors
-
Kivela A, Parkkila S, Saarnio J et al. Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. Am. J. Pathol. 156, 577-584 (2000
-
(2000)
Am. J. Pathol
, vol.156
, pp. 577-584
-
-
Kivela, A.1
Parkkila, S.2
Saarnio, J.3
-
136
-
-
78649656359
-
Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis
-
Ilie MI, Hofman V, Ortholan C et al. Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis. Int. J. Cancer 128, 1614-1623 (2011
-
(2011)
Int. J. Cancer
, vol.128
, pp. 1614-1623
-
-
Ilie, M.I.1
Hofman, V.2
Ortholan, C.3
-
137
-
-
8844249356
-
Hypoxia activates the capacity of tumor-Associated carbonic anhydrase IX to acidify extracellular pH
-
SvastovaáE, HuliákovaáA, RafajovaáM et alHypoxia activates the capacity of tumor-Associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 577, 439-445 (2004
-
(2004)
FEBS Lett
, vol.577
, pp. 439-445
-
-
Svastovaá, E.1
Huliákovaá, A.2
Rafajovaá, M.3
-
138
-
-
79952808077
-
Ureidosubstituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis
-
Pacchiano F, Carta F, McDonald PC et al. Ureidosubstituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J. Med. Chem. 54, 1896-1902 (2011
-
(2011)
J. Med. Chem
, vol.54
, pp. 1896-1902
-
-
Pacchiano, F.1
Carta, F.2
McDonald, P.C.3
-
139
-
-
84887098421
-
Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche
-
Lock FE, McDonald PC, Lou Y et al. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Oncogene 32, 5210-5219 (2012
-
(2012)
Oncogene
, vol.32
, pp. 5210-5219
-
-
Lock, F.E.1
McDonald, P.C.2
Lou, Y.3
-
140
-
-
79952808077
-
Ureidosubstituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis
-
Pacchiano F, Carta F, McDonald PC et al. Ureidosubstituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J. Med. Chem. 54, 1896-1902 (2011
-
(2011)
J. Med. Chem
, vol.54
, pp. 1896-1902
-
-
Pacchiano, F.1
Carta, F.2
McDonald, P.C.3
-
141
-
-
84905444266
-
-
Stichting Maastricht Radiation Oncology Maastro Clinic
-
Stichting Maastricht Radiation Oncology Maastro Clinic; Dubois LJ, Lambin P et al.: WO087115 (2012
-
(2012)
WO087115
-
-
Dubois, L.J.1
Lambin, P.2
-
142
-
-
84865962997
-
Bacterial carbonic anhydrases as drug targets: Toward novel antibiotics
-
Supuran CT. Bacterial carbonic anhydrases as drug targets: Toward novel antibioticsés Front. Pharmacol. 2, 34 (2011
-
(2011)
Front Pharmacol
, vol.2
, Issue.34
-
-
Supuran, C.T.1
-
143
-
-
84878041301
-
Anti-infective carbonic anhydrase inhibitors: A patent and literature review
-
Capasso C, Supuran CT. Anti-infective carbonic anhydrase inhibitors: A patent and literature review. Expert Opin. Ther. Pat. 23, 693-704 (2013
-
(2013)
Expert Opin. Ther. Pat
, vol.23
, pp. 693-704
-
-
Capasso, C.1
Supuran, C.T.2
-
144
-
-
53549094659
-
Carbonic anhydrase inhibitors Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides: In vitro and in vivo studies
-
Krungkrai J, Krungkrai SR, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/ heterocyclic sulfonamides: In vitro and in vivo studies. Bioorg. Med. Chem. Lett. 18, 5466-5471 (2008
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, pp. 5466-5471
-
-
Krungkrai, J.1
Krungkrai, S.R.2
Supuran, C.T.3
-
145
-
-
84874592654
-
Cloning, characterization, sulfonamide and thiol inhibition studies of an alpha-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease
-
Pan P, Vermelho AB, Capaci Rodrigues G et al. Cloning, characterization, sulfonamide and thiol inhibition studies of an alpha-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease. J. Med. Chem. 56, 1761-1771 (2013
-
(2013)
J. Med. Chem
, vol.56
, pp. 1761-1771
-
-
Pan, P.1
Vermelho, A.B.2
Capaci Rodrigues, G.3
-
146
-
-
84864247706
-
Polypharmacology of sulfonamides: Pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases
-
Winum JY, Maresca A, Carta F, Scozzafava A, Supuran CT. Polypharmacology of sulfonamides: Pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases. Chem. Commun. 48, 8177-8179 (2012.
-
(2012)
Chem. Commun
, vol.48
, pp. 8177-8179
-
-
Winum, J.Y.1
Maresca, A.2
Carta, F.3
Scozzafava, A.4
Supuran, C.T.5
|